Home > Medicine & Health Science textbooks > Clinical and internal medicine > Cancer Bioinformatics – From Therapy Design to Treatment
3%
Cancer Bioinformatics – From Therapy Design to Treatment

Cancer Bioinformatics – From Therapy Design to Treatment

          
5
4
3
2
1

Out of Stock


Premium quality
Premium quality
Bookswagon upholds the quality by delivering untarnished books. Quality, services and satisfaction are everything for us!
Easy Return
Easy return
Not satisfied with this product! Keep it in original condition and packaging to avail easy return policy.
Certified product
Certified product
First impression is the last impression! Address the book’s certification page, ISBN, publisher’s name, copyright page and print quality.
Secure Checkout
Secure checkout
Security at its finest! Login, browse, purchase and pay, every step is safe and secured.
Money back guarantee
Money-back guarantee:
It’s all about customers! For any kind of bad experience with the product, get your actual amount back after returning the product.
On time delivery
On-time delivery
At your doorstep on time! Get this book delivered without any delay.
Notify me when this book is in stock
Add to Wishlist

About the Book

"The development and application of bioinformatics tools to basic and translational cancer research is, in fact, a rapidly expanding field that deserves a timely review. Therefore, a publication of this type is needed. The editors have done an excellent job in recruiting well-established scientists to author the various chapters of the book." -Dieter Naf, Jackson Laboratory, USA Cancer bioinformatics is now emerging as a new interdisciplinary field, which is facilitating an unprecedented synthesis of knowledge arising from the life and clinical sciences. This groundbreaking title provides a comprehensive and up-to-date account of the enormous range of bioinformatics for cancer therapy development from the laboratory to clinical trials. It functions as a guide to integrated data exploitation and synergistic knowledge discovery, and support the consolidation of the interdisciplinary research community involved.

Table of Contents:
Preface. List of Contributors. SECTION I CANCER SYSTEMS. 1 A Path to Knowledge: from Data to Complex Systems Models of Cancer (Sylvia Nagl). 1.1 Conceptual foundations: biological complexity. 1.2 A taxonomy of cancer complexity. 1.3 Modelling and simulation of cancer systems. 1.4 Data standards and integration. 1.5 Concluding remarks. 2 Theory of Cancer Robustness (Hiroaki Kitano). 2.1 Robustness: the fundamental organizational principle of biological systems. 2.2 Underlying mechanisms for robustness. 2.3 Intrinsic features of robust systems: evolvability and trade-offs. 2.4 Cancer as a robust system. 2.5 Therapy strategies. 2.6 A proper index of treatment efficacy. 2.7 Computational tools. 2.8 Conclusion. 3 Developing an Integrated Informatics Platform for Cancer Research (Richard Begent). 3.1 Background. 3.2 The challenge. 3.3 The UK National Cancer Research Institute (NCRI) informatics platform. 3.4 Developing the informatics platform. 3.5 Benefits of the platform. 3.6 Conclusions. SECTION II In silico MODELS. 4 Mathematical Models of Cancer (Manish Patel and Sylvia Nagl). 4.1 Growth models. 4.2 A very brief tour of cellular automata. 4.3 Angiogenesis models. 4.4 Treatment response models. 4.5 Dynamic pathways models. 4.6 Other models. 4.7 Simulations of complex biological systems. 4.8 Concluding remarks. 5 Some Mathematical Modelling Challenges and Approaches in Cancer (Philip Maini and Robert A. Gatenby). 5.1 Introduction. 5.2 Multiscale modelling. 5.3 Tumour vascular modelling. 5.4 Population models. 5.5 Conclusion. 6 Computer Simulation of Tumour Response to Therapy (Georgios S. Stamatakos and Nikolaos Uzunoglu). 6.1 Introduction. 6.2 Tumour growth simulation. 6.3 Radiotherapy response simulation. 6.4 Chemotherapy response simulation. 6.5 Simulation of tumour response to other therapeutic modalities. 6.6 Simulation of normal tissue response to antineoplastic interventions. 6.7 Integration of molecular networks into tumour behaviour simulations. 6.8 Future directions. 7 Structural Bioinformatics in Cancer (Stephen Neidle). 7.1 Introduction. 7.2 Macromolecular crystallography. 7.3 Molecular modelling. 7.4 Conclusions. SECTION III In vivo MODELS. 8 The Mouse Tumour Biology Database: an Online Resource for Mouse Models of Human Cancer (Carol J. Bult, Debra M. Krupke, Matthew J. Vincent, Theresa Allio, John P. Sundberg, Igor Mikaelian and Janan T. Eppig). 8.1 Introduction. 8.2 Background. 8.3 Database content. 8.4 Data acquisition. 8.5 Using the MTB database. 8.6 Connecting the MTB database with related databases. 8.7 Summary. 9 Bioinformatics Approaches to Integrate Cancer Models and Human Cancer Research (Cheryl L. Marks and Sue Dubman). 9.1 Background. 9.2 The MMHCC Informatics at the outset of the programme. 9.3 Initial NCI bioinformatics infrastructure development. 9.4 Future directions for informatics support. 9.5 Summary. SECTION IV DATA. 10 The FAPESP/LICR Human Cancer Genome Project: Perspectives on Integration (Ricardo Brentani, Anamaria A. Camargo, Helena Brentani and Sandro J. De Souza). 10.1 Introduction. 10.2 The FAPESP/LICR Human Cancer Genome Project. 10.3 An integrated view of the tumour transcriptome. 10.4 Summary. 11 Today's Science, Tomorrow's Patient: the Pivotal Role of Tissue, Clinical Data and Informatics in Modern Drug Development (Kirstine Knox, Amanda Taylor and David J. Kerr). 11.1 Introduction. 11.2 A new national strategy for the provision of tissue annotated with clinical information to meet current and future needs of academic researchers and industry. 11.3 The NCRI National Cancer Tissue Resource for cancer biology and treatment development. 11.4 A potential future world-class resource integrating research and health service information systems and bioinformatics for cancer diagnosis and treatment. 11.5 A proposed information system architecture that will meet the challenges and deliver the required functionality: an overview. 11.6 Consent and confidentiality: ensuring that the NCTR is embedded in the UK's legal and ethical framework. 11.7 Concluding remarks: future challenges and opportunities. SECTION V ETHICS. 12 Software Design Ethics for Biomedicine (Don Gotterbarn and Simon Rogerson). 12.1 The problem: software and research. 12.2 Risk identification. 12.3 Biomedical software example. 12.4 Is an ethical risk analysis required? 12.5 Details of SoDIS. 12.6 A SoDIS analysis of the biomedical software example. 12.7 Conclusion. 13 Ethical Issues of Electronic Patient Data and Informatics in Clinical Trial Settings (Dipak Kalra and David Ingram). 13.1 Introduction. 13.2 Ethical aspects of using patient-identifiable health data. 13.3 Legislation and policies pertaining to patient-identifiable health data. 13.4 Using anonymized and pseudonymized data. 13.5 Protecting personal health data. 14 Pharmacogenomics and Cancer: Ethical, Legal and Social Issues (Mary Anderlik Majumder and Mark Rothstein). 14.1 Introduction. 14.2 Getting pharmacogenomic tests and drugs to market. 14.3 Cost and coverage issues. 14.4 Ethical challenges of pharmacogenomics. 14.5 Conclusion. Index


Best Sellers


Product Details
  • ISBN-13: 9780470032893
  • Publisher: John Wiley and Sons Ltd
  • Publisher Imprint: John Wiley & Sons Ltd
  • Height: 250 mm
  • No of Pages: 300
  • Spine Width: 24 mm
  • Width: 180 mm
  • ISBN-10: 0470032898
  • Publisher Date: 16 May 2006
  • Binding: Other digital
  • Language: English
  • Returnable: Y
  • Weight: 728 gr


Similar Products

How would you rate your experience shopping for books on Bookswagon?

Add Photo
Add Photo

Customer Reviews

REVIEWS           
Click Here To Be The First to Review this Product
Cancer Bioinformatics – From Therapy Design to Treatment
John Wiley and Sons Ltd -
Cancer Bioinformatics – From Therapy Design to Treatment
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Cancer Bioinformatics – From Therapy Design to Treatment

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book
    Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    New Arrivals


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!
    ASK VIDYA